table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Narcotic (Opioid) Drugs Market Size Analysis from 2022 to 2027
1.5.1 Global Narcotic (Opioid) Drugs Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Narcotic (Opioid) Drugs Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Narcotic (Opioid) Drugs Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Narcotic (Opioid) Drugs Industry Impact
Chapter 2 Global Narcotic (Opioid) Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Narcotic (Opioid) Drugs (Volume and Value) by Type
2.1.1 Global Narcotic (Opioid) Drugs Consumption and Market Share by Type (2016-2021)
2.1.2 Global Narcotic (Opioid) Drugs Revenue and Market Share by Type (2016-2021)
2.2 Global Narcotic (Opioid) Drugs (Volume and Value) by Application
2.2.1 Global Narcotic (Opioid) Drugs Consumption and Market Share by Application (2016-2021)
2.2.2 Global Narcotic (Opioid) Drugs Revenue and Market Share by Application (2016-2021)
2.3 Global Narcotic (Opioid) Drugs (Volume and Value) by Regions
2.3.1 Global Narcotic (Opioid) Drugs Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Narcotic (Opioid) Drugs Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Narcotic (Opioid) Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Narcotic (Opioid) Drugs Consumption by Regions (2016-2021)
4.2 North America Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
4.10 South America Narcotic (Opioid) Drugs Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Narcotic (Opioid) Drugs Market Analysis
5.1 North America Narcotic (Opioid) Drugs Consumption and Value Analysis
5.1.1 North America Narcotic (Opioid) Drugs Market Under COVID-19
5.2 North America Narcotic (Opioid) Drugs Consumption Volume by Types
5.3 North America Narcotic (Opioid) Drugs Consumption Structure by Application
5.4 North America Narcotic (Opioid) Drugs Consumption by Top Countries
5.4.1 United States Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
5.4.2 Canada Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
5.4.3 Mexico Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 6 East Asia Narcotic (Opioid) Drugs Market Analysis
6.1 East Asia Narcotic (Opioid) Drugs Consumption and Value Analysis
6.1.1 East Asia Narcotic (Opioid) Drugs Market Under COVID-19
6.2 East Asia Narcotic (Opioid) Drugs Consumption Volume by Types
6.3 East Asia Narcotic (Opioid) Drugs Consumption Structure by Application
6.4 East Asia Narcotic (Opioid) Drugs Consumption by Top Countries
6.4.1 China Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
6.4.2 Japan Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
6.4.3 South Korea Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 7 Europe Narcotic (Opioid) Drugs Market Analysis
7.1 Europe Narcotic (Opioid) Drugs Consumption and Value Analysis
7.1.1 Europe Narcotic (Opioid) Drugs Market Under COVID-19
7.2 Europe Narcotic (Opioid) Drugs Consumption Volume by Types
7.3 Europe Narcotic (Opioid) Drugs Consumption Structure by Application
7.4 Europe Narcotic (Opioid) Drugs Consumption by Top Countries
7.4.1 Germany Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.2 UK Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.3 France Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.4 Italy Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.5 Russia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.6 Spain Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.7 Netherlands Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.8 Switzerland Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
7.4.9 Poland Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 8 South Asia Narcotic (Opioid) Drugs Market Analysis
8.1 South Asia Narcotic (Opioid) Drugs Consumption and Value Analysis
8.1.1 South Asia Narcotic (Opioid) Drugs Market Under COVID-19
8.2 South Asia Narcotic (Opioid) Drugs Consumption Volume by Types
8.3 South Asia Narcotic (Opioid) Drugs Consumption Structure by Application
8.4 South Asia Narcotic (Opioid) Drugs Consumption by Top Countries
8.4.1 India Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
8.4.2 Pakistan Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Narcotic (Opioid) Drugs Market Analysis
9.1 Southeast Asia Narcotic (Opioid) Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Narcotic (Opioid) Drugs Market Under COVID-19
9.2 Southeast Asia Narcotic (Opioid) Drugs Consumption Volume by Types
9.3 Southeast Asia Narcotic (Opioid) Drugs Consumption Structure by Application
9.4 Southeast Asia Narcotic (Opioid) Drugs Consumption by Top Countries
9.4.1 Indonesia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
9.4.2 Thailand Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
9.4.3 Singapore Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
9.4.4 Malaysia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
9.4.5 Philippines Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
9.4.6 Vietnam Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
9.4.7 Myanmar Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 10 Middle East Narcotic (Opioid) Drugs Market Analysis
10.1 Middle East Narcotic (Opioid) Drugs Consumption and Value Analysis
10.1.1 Middle East Narcotic (Opioid) Drugs Market Under COVID-19
10.2 Middle East Narcotic (Opioid) Drugs Consumption Volume by Types
10.3 Middle East Narcotic (Opioid) Drugs Consumption Structure by Application
10.4 Middle East Narcotic (Opioid) Drugs Consumption by Top Countries
10.4.1 Turkey Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.3 Iran Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.5 Israel Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.6 Iraq Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.7 Qatar Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.8 Kuwait Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
10.4.9 Oman Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 11 Africa Narcotic (Opioid) Drugs Market Analysis
11.1 Africa Narcotic (Opioid) Drugs Consumption and Value Analysis
11.1.1 Africa Narcotic (Opioid) Drugs Market Under COVID-19
11.2 Africa Narcotic (Opioid) Drugs Consumption Volume by Types
11.3 Africa Narcotic (Opioid) Drugs Consumption Structure by Application
11.4 Africa Narcotic (Opioid) Drugs Consumption by Top Countries
11.4.1 Nigeria Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
11.4.2 South Africa Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
11.4.3 Egypt Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
11.4.4 Algeria Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
11.4.5 Morocco Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 12 Oceania Narcotic (Opioid) Drugs Market Analysis
12.1 Oceania Narcotic (Opioid) Drugs Consumption and Value Analysis
12.2 Oceania Narcotic (Opioid) Drugs Consumption Volume by Types
12.3 Oceania Narcotic (Opioid) Drugs Consumption Structure by Application
12.4 Oceania Narcotic (Opioid) Drugs Consumption by Top Countries
12.4.1 Australia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
12.4.2 New Zealand Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 13 South America Narcotic (Opioid) Drugs Market Analysis
13.1 South America Narcotic (Opioid) Drugs Consumption and Value Analysis
13.1.1 South America Narcotic (Opioid) Drugs Market Under COVID-19
13.2 South America Narcotic (Opioid) Drugs Consumption Volume by Types
13.3 South America Narcotic (Opioid) Drugs Consumption Structure by Application
13.4 South America Narcotic (Opioid) Drugs Consumption Volume by Major Countries
13.4.1 Brazil Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.2 Argentina Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.3 Columbia Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.4 Chile Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.5 Venezuela Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.6 Peru Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
13.4.8 Ecuador Narcotic (Opioid) Drugs Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Narcotic (Opioid) Drugs Business
14.1 Pfizer
14.1.1 Pfizer Company Profile
14.1.2 Pfizer Narcotic (Opioid) Drugs Product Specification
14.1.3 Pfizer Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Merck
14.2.1 Merck Company Profile
14.2.2 Merck Narcotic (Opioid) Drugs Product Specification
14.2.3 Merck Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Mallinckrodt
14.3.1 Mallinckrodt Company Profile
14.3.2 Mallinckrodt Narcotic (Opioid) Drugs Product Specification
14.3.3 Mallinckrodt Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Teva
14.4.1 Teva Company Profile
14.4.2 Teva Narcotic (Opioid) Drugs Product Specification
14.4.3 Teva Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Johnson & Johnson
14.5.1 Johnson & Johnson Company Profile
14.5.2 Johnson & Johnson Narcotic (Opioid) Drugs Product Specification
14.5.3 Johnson & Johnson Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Purdue Pharma
14.6.1 Purdue Pharma Company Profile
14.6.2 Purdue Pharma Narcotic (Opioid) Drugs Product Specification
14.6.3 Purdue Pharma Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Hikma Pharmaceuticals
14.7.1 Hikma Pharmaceuticals Company Profile
14.7.2 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product Specification
14.7.3 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Collegium
14.8.1 Collegium Company Profile
14.8.2 Collegium Narcotic (Opioid) Drugs Product Specification
14.8.3 Collegium Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Amneal Pharma
14.9.1 Amneal Pharma Company Profile
14.9.2 Amneal Pharma Narcotic (Opioid) Drugs Product Specification
14.9.3 Amneal Pharma Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Mylan
14.10.1 Mylan Company Profile
14.10.2 Mylan Narcotic (Opioid) Drugs Product Specification
14.10.3 Mylan Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Sun Pharma
14.11.1 Sun Pharma Company Profile
14.11.2 Sun Pharma Narcotic (Opioid) Drugs Product Specification
14.11.3 Sun Pharma Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Endo Pharmaceuticals
14.12.1 Endo Pharmaceuticals Company Profile
14.12.2 Endo Pharmaceuticals Narcotic (Opioid) Drugs Product Specification
14.12.3 Endo Pharmaceuticals Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 Allergan
14.13.1 Allergan Company Profile
14.13.2 Allergan Narcotic (Opioid) Drugs Product Specification
14.13.3 Allergan Narcotic (Opioid) Drugs Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Narcotic (Opioid) Drugs Market Forecast (2022-2027)
15.1 Global Narcotic (Opioid) Drugs Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Narcotic (Opioid) Drugs Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Narcotic (Opioid) Drugs Value and Growth Rate Forecast (2022-2027)
15.2 Global Narcotic (Opioid) Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Narcotic (Opioid) Drugs Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Narcotic (Opioid) Drugs Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Narcotic (Opioid) Drugs Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Narcotic (Opioid) Drugs Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Narcotic (Opioid) Drugs Consumption Forecast by Type (2022-2027)
15.3.2 Global Narcotic (Opioid) Drugs Revenue Forecast by Type (2022-2027)
15.3.3 Global Narcotic (Opioid) Drugs Price Forecast by Type (2022-2027)
15.4 Global Narcotic (Opioid) Drugs Consumption Volume Forecast by Application (2022-2027)
15.5 Narcotic (Opioid) Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
